asco: pembrolizumab vs. chemotherapy for msi-h metastatic colorectal cancer
Published 4 years ago • 267 plays • Length 4:56Download video MP4
Download video MP3
Similar videos
-
6:56
keynote-177 results: pembrolizumab versus chemotherapy for patients with msi-h/dmmr colorectal c...
-
0:46
dual checkpoint inhibitors for msi high colorectal cancer
-
2:11
pembrolizumab vs. chemo in first-line mcrc
-
5:20
pembrolizumab improves on chemo in msi-h/dmmr mcrc
-
1:35
dr. chu on the role of pembrolizumab in dmmr/msi-h mcrc
-
9:02
pembrolizumab in msi-h crc tumors
-
2:56
keynote-177: final pfs analysis of pembrolizumab in patients with msi-h/dmmr mcrc
-
7:37
debate: msi high colon cancer - upfront chemotherapy
-
10:14
asco: pembrolizumab plus chemotherapy for advanced triple-negative breast cancer
-
3:40
asco 2024 top 5 pembrolizumab vs. chemotherapy for sarcoma questions
-
9:25
debate: msi high colon cancer - immunotherapy
-
8:40
thierry andre, asco20: phase iii keynote-177 trial of pembrolizumab in metastatic colorectal cancer
-
4:49
hrqol of pembrolizumab vs. chemotherapy for previously treated...
-
2:08
nc410 and pembrolizumab in mss/msi-l colorectal (crc) and ovarian cancer
-
29:15
icaho20 - asco direct™ highlights - dr. axel grothey - colorectal cancer
-
4:08
2021 asco direct san francisco | colorectal cancer summary | dr. chloe atreya
-
0:48
ctdna in clinical practice for colon cancer
-
7:10
2021 asco direct jacksonville | colorectal cancer summary | dr. louise connell
-
1:28
dr. bekaii-saab on the response rate of pembrolizumab in msi-h crc